Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock-a critical appraisal of current data.
Bernhard WernlyClemens SeelmaierDavid LeistnerBarbara E StähliIngrid PretschMichael LichtenauerChristian JungUta C HoppeUlf LandmesserHolger ThieleAlexander LautenPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2019)
In patients suffering from severe CS due to AMI, the use of Impella is not associated with improved short-time survival but with higher complications rates compared to IABP and medical treatment. Better patient selection avoiding Impella implantation in futile situations or in possible lower risk CS might be necessary to elucidate possible advantages of Impella in future studies.
Keyphrases
- extracorporeal membrane oxygenation
- end stage renal disease
- healthcare
- left ventricular assist device
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- heart failure
- prognostic factors
- big data
- case report
- current status
- artificial intelligence
- drug induced
- deep learning
- free survival
- pulmonary arterial hypertension